Mozobil Injection, Solution
Product Images NDC 0024-5862

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mozobil (NDC 0024-5862). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Structural Formula (Mozobil 01)

Chemical structure of PLERIXAFOR, the active ingredient in Mozobil injection, solution. The diagram shows the molecular arrangement including two macrocyclic rings connected by a benzene ring, representing the structural formula.*

FDA Label Image

Principal Display Panel (1.2 mL Vial Carton)

Packaging label for Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) subcutaneous injection by Sanofi Genzyme, a Sanofi company. The label includes NDC 0024-5862-01, storage instructions, composition details, and usage notes, emphasizing single-dose vial usage and Rx only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.